|1.||Deroo, Scott: 1 article (08/2012)|
|2.||Kumar-Sinha, Chandan: 1 article (08/2012)|
|3.||Iyer, Matthew K: 1 article (08/2012)|
|4.||Kalyana-Sundaram, Shanker: 1 article (08/2012)|
|5.||Chinnaiyan, Arul M: 1 article (08/2012)|
|6.||Shankar, Sunita: 1 article (08/2012)|
|7.||Palanisamy, Nallasivam: 1 article (08/2012)|
|8.||Aguilera, Nadine: 1 article (03/2009)|
|9.||Burger, Angelika M: 1 article (03/2009)|
|10.||Rapoport, Aaron P: 1 article (03/2009)|
04/05/1993 - "Further studies show that the same four major Ser/Thr-Pro sites associated with p70s6k activation following mitogenic stimulation in vivo are also the four major sites phosphorylated in both the p70s6k and p85s6k during the infection process. "
04/05/1993 - "It is proposed that the production of phosphorylated and activated recombinant p70s6k and p85s6k is due to activation of a host cell signaling pathway which is triggered by viral infection. "
|2.||Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
|4.||Breast Neoplasms (Breast Cancer)
08/01/2012 - "As illustrative examples of the "amplicon-associated" gene fusions, we examined here a recurrent gene fusion involving the mediator of mammalian target of rapamycin signaling, RPS6KB1 kinase in BT-474, and the therapeutically important receptor tyrosine kinase EGFR in MDA-MB-468 breast cancer cell line. "
|1.||70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
|4.||tyrosine receptor (receptor, tyrosine)